N-2,3-Xylylanthranilic-d4 Acid; 2-(2,3-Dimethylanilino)benzoic-d4 Acid; 2-[(2,3-Dimethylphenyl)amino]benzoic-d4 Acid; 2',3'-Dimethyl-N-phenylanthranilic-d4 Acid; Bafameritin M-d4; Baphameritin M-d4; Bonabol-d4; C.I. 473-d4; CN 35355-d4; Coslan-d4; INF 3355-d4; In-M-d4; Lysalgo-d4; Mefacit-d4; Mefenacid-d4; Mefenamic-d4 Acid; Mephenamic-d4 Acid; N-(2,3-Dimethylphenyl)anthranilic-d4 Acid; N-(2,3-Xylyl)-2-aminobenzoic-d4 Acid; N-(2,3-Xylyl)anthranilic-d4 Acid; NSC 94437-d4; Namphen-d4; Parkemed-d4; Ponalar-d4; Ponstan-d4; Ponstel-d4; Ponstil-d4; Ponstyl-d4; Pontal-d4; Relafan-d4; Tanston-d4; Vialidon-d4;Mefenamic-d4 Acid
Mefenamic Acid-d4 is a fully characterized chemical compound used as a reference standard of API Mefenamic Acid. The standard offered is compliant with regulatory guidelines. Mefenamic Acid-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1216745-79-7